<?xml version="1.0" encoding="UTF-8" ?><rss version="2.0">
	<channel>
	    <title><![CDATA[Clinical Pharmacology: Advances and Applications]]></title>
	    <description><![CDATA[An international, peer-reviewed, open access, online journal, publishing original research, reports, reviews and commentaries on all areas of drug experience in humans. ]]></description>
	    <link>http://dovepress.com/clinical-pharmacology-advances-and-applications-journal</link>
	    			<item>
    			<title><![CDATA[Reporting of results of interventional studies by the information service of the National Institutes of Health]]></title>
				<description><![CDATA[Tatyana Shamliyan]]></description>
				<link>http://dovepress.com/reporting-of-results-of-interventional-studiesby-the-information-servi-peer-reviewed-article-CPAA</link>
				<guid isPermaLink="true">http://dovepress.com/reporting-of-results-of-interventional-studiesby-the-information-servi-peer-reviewed-article-CPAA</guid>
			</item>
	    			<item>
    			<title><![CDATA[Testosterone replacement in male hypogonadism]]></title>
				<description><![CDATA[Sanjay Kalra, Navneet Agrawal, Satish Kumar, et al]]></description>
				<link>http://dovepress.com/testosterone-replacement-in-male-hypogonadism-peer-reviewed-article-CPAA</link>
				<guid isPermaLink="true">http://dovepress.com/testosterone-replacement-in-male-hypogonadism-peer-reviewed-article-CPAA</guid>
			</item>
	    			<item>
    			<title><![CDATA[The interaction between clopidogrel and proton pump inhibitors (PPI): is there any clinical relevance?]]></title>
				<description><![CDATA[Rakesh K Sharma, Hanumanth K Reddy, Rohit K Sharma, et al]]></description>
				<link>http://dovepress.com/the-interaction-between-clopidogrel-and-proton-pump-inhibitors-ppi-is--peer-reviewed-article-CPAA</link>
				<guid isPermaLink="true">http://dovepress.com/the-interaction-between-clopidogrel-and-proton-pump-inhibitors-ppi-is--peer-reviewed-article-CPAA</guid>
			</item>
	    			<item>
    			<title><![CDATA[Differences in hospital glycemic control and insulin requirements in patients recovering from critical illness and those without prior critical illness]]></title>
				<description><![CDATA[April D Miller, Leslie M Phillips, Richard M Schulz, et al]]></description>
				<link>http://dovepress.com/differences-in-hospital-glycemic-control-and-insulin-requirements-in-p-peer-reviewed-article-CPAA</link>
				<guid isPermaLink="true">http://dovepress.com/differences-in-hospital-glycemic-control-and-insulin-requirements-in-p-peer-reviewed-article-CPAA</guid>
			</item>
	    			<item>
    			<title><![CDATA[Rituximab in severe skin diseases: target, disease, and dose]]></title>
				<description><![CDATA[Daniel D Bennett, Maro Ohanian, Christian T Cable]]></description>
				<link>http://dovepress.com/rituximab-in-severe-skin-diseases-target-disease-and-dose-peer-reviewed-article-CPAA</link>
				<guid isPermaLink="true">http://dovepress.com/rituximab-in-severe-skin-diseases-target-disease-and-dose-peer-reviewed-article-CPAA</guid>
			</item>
	    			<item>
    			<title><![CDATA[Managing insulin resistance: role of liraglutide]]></title>
				<description><![CDATA[Sanjay Kalra, Bharti Kalra, Satish Kumar, et al]]></description>
				<link>http://dovepress.com/managing-insulin-resistance-role-of-liraglutide-peer-reviewed-article-CPAA</link>
				<guid isPermaLink="true">http://dovepress.com/managing-insulin-resistance-role-of-liraglutide-peer-reviewed-article-CPAA</guid>
			</item>
	    			<item>
    			<title><![CDATA[A common variant in the adiponectin gene on weight loss and body composition under sibutramine therapy in obesity]]></title>
				<description><![CDATA[Tun-Jen Hsiao, Lawrence Shih-Hsin Wu, Shih-Yi Huang, et al]]></description>
				<link>http://dovepress.com/a-common-variant-in-the-adiponectin-gene-on-weight-loss-and-body-compo-peer-reviewed-article-CPAA</link>
				<guid isPermaLink="true">http://dovepress.com/a-common-variant-in-the-adiponectin-gene-on-weight-loss-and-body-compo-peer-reviewed-article-CPAA</guid>
			</item>
	    			<item>
    			<title><![CDATA[Clinical outcomes of antimicrobial lock solutions used in a treatment modality: a retrospective case series analysis]]></title>
				<description><![CDATA[P Brandon Bookstaver, Katherine R Gerrald, Robert R Moran]]></description>
				<link>http://dovepress.com/clinical-outcomes-of-antimicrobial-lock-solutions-used-in-a-treatment--peer-reviewed-article-CPAA</link>
				<guid isPermaLink="true">http://dovepress.com/clinical-outcomes-of-antimicrobial-lock-solutions-used-in-a-treatment--peer-reviewed-article-CPAA</guid>
			</item>
	    			<item>
    			<title><![CDATA[Lanthanum carbonate is not associated with QT interval modification in hemodialysis patients]]></title>
				<description><![CDATA[Biagio Di Iorio, Emanuele Cucciniello]]></description>
				<link>http://dovepress.com/lanthanum-carbonate-is-not-associated-with-qt-interval-modification-in-peer-reviewed-article-CPAA</link>
				<guid isPermaLink="true">http://dovepress.com/lanthanum-carbonate-is-not-associated-with-qt-interval-modification-in-peer-reviewed-article-CPAA</guid>
			</item>
	    			<item>
    			<title><![CDATA[Somatotropin in the treatment of growth hormone deficiency and Turner syndrome in pediatric patients: a review]]></title>
				<description><![CDATA[Christina Southern Reh, Mitchell E Geffner]]></description>
				<link>http://dovepress.com/somatotropin-in-the-treatment-of-growth-hormone-deficiency-and-turner--peer-reviewed-article-CPAA</link>
				<guid isPermaLink="true">http://dovepress.com/somatotropin-in-the-treatment-of-growth-hormone-deficiency-and-turner--peer-reviewed-article-CPAA</guid>
			</item>
	    			<item>
    			<title><![CDATA[A review on the rationale and clinical use of concomitant rosuvastatin and fenofibrate/fenofibric acid therapy]]></title>
				<description><![CDATA[Joe D Strain, Debra K Farver, James R Clem]]></description>
				<link>http://dovepress.com/a-review-on-the-rationale-and-clinical-use-of-concomitant-rosuvastatin-peer-reviewed-article-CPAA</link>
				<guid isPermaLink="true">http://dovepress.com/a-review-on-the-rationale-and-clinical-use-of-concomitant-rosuvastatin-peer-reviewed-article-CPAA</guid>
			</item>
	    			<item>
    			<title><![CDATA[Adverse drug effects in hospitalized elderly: Data from the Healthcare Cost and Utilization Project]]></title>
				<description><![CDATA[Tatyana Shamliyan]]></description>
				<link>http://dovepress.com/adverse-drug-effects-in-hospitalized-elderly-data-from-the-healthcare--peer-reviewed-article-CPAA</link>
				<guid isPermaLink="true">http://dovepress.com/adverse-drug-effects-in-hospitalized-elderly-data-from-the-healthcare--peer-reviewed-article-CPAA</guid>
			</item>
	    			<item>
    			<title><![CDATA[Cosyntropin as a diagnostic agent in the screening of patients for adrenocortical insufficiency]]></title>
				<description><![CDATA[David D Hamilton, Bryan A Cotton]]></description>
				<link>http://dovepress.com/cosyntropin-as-a-diagnostic-agent-in-the-screening-of-patients-for-adr-peer-reviewed-article-CPAA</link>
				<guid isPermaLink="true">http://dovepress.com/cosyntropin-as-a-diagnostic-agent-in-the-screening-of-patients-for-adr-peer-reviewed-article-CPAA</guid>
			</item>
	    			<item>
    			<title><![CDATA[Effect of rosiglitazone and ramipril on macrovasculopathy in patients with type 2 diabetes: needs longer&nbsp; treatment and/or higher doses?]]></title>
				<description><![CDATA[Sayeeda Rahman, Aziz Al-Shafi Ismail, Shaiful Bhari Ismail, et al]]></description>
				<link>http://dovepress.com/effect-of-rosiglitazone-and-ramipril-on-macrovasculopathy-in-patients--peer-reviewed-article-CPAA</link>
				<guid isPermaLink="true">http://dovepress.com/effect-of-rosiglitazone-and-ramipril-on-macrovasculopathy-in-patients--peer-reviewed-article-CPAA</guid>
			</item>
	    			<item>
    			<title><![CDATA[Induction chemotherapy before autologous stem cell transplantation for symptomatic plasma cell myeloma &ndash; does it matter?]]></title>
				<description><![CDATA[Henry C Fung, Sunita Nathan, John J Maciejewski]]></description>
				<link>http://dovepress.com/induction-chemotherapy-before-autologous-stem-cell-transplantation-for-peer-reviewed-article-CPAA</link>
				<guid isPermaLink="true">http://dovepress.com/induction-chemotherapy-before-autologous-stem-cell-transplantation-for-peer-reviewed-article-CPAA</guid>
			</item>
	    			<item>
    			<title><![CDATA[Pharmacologic agents for smoking cessation: A clinical review]]></title>
				<description><![CDATA[Dilip R Patel, Cynthia Feucht, Lesley Reid, et al]]></description>
				<link>http://dovepress.com/pharmacologic-agents-for-smoking-cessation-a-clinical-review-peer-reviewed-article-CPAA</link>
				<guid isPermaLink="true">http://dovepress.com/pharmacologic-agents-for-smoking-cessation-a-clinical-review-peer-reviewed-article-CPAA</guid>
			</item>
	    			<item>
    			<title><![CDATA[NMDA receptors are expressed by small-cell lung cancer and are potential targets for effective treatment]]></title>
				<description><![CDATA[William G North, Guohong Gao, Amy Jensen, et al]]></description>
				<link>http://dovepress.com/nmda-receptors-are-expressed-by-small-cell-lung-cancer-and-are-potenti-peer-reviewed-article-CPAA</link>
				<guid isPermaLink="true">http://dovepress.com/nmda-receptors-are-expressed-by-small-cell-lung-cancer-and-are-potenti-peer-reviewed-article-CPAA</guid>
			</item>
	    			<item>
    			<title><![CDATA[Lidocaine 5% patch for localized neuropathic pain: progress for the patient, a new approach for the physician]]></title>
				<description><![CDATA[Guy Hans, Dominique Robert, Johanna Verhulst, et al]]></description>
				<link>http://dovepress.com/lidocaine-5-patch-for-localized-neuropathic-pain-progress-for-the-pati-peer-reviewed-article-CPAA</link>
				<guid isPermaLink="true">http://dovepress.com/lidocaine-5-patch-for-localized-neuropathic-pain-progress-for-the-pati-peer-reviewed-article-CPAA</guid>
			</item>
	    			<item>
    			<title><![CDATA[Nanoparticle-labeled stem cells: a novel therapeutic vehicle]]></title>
				<description><![CDATA[Abir O El-Sadik, Afaf El-Ansary, Sherif M Sabry]]></description>
				<link>http://dovepress.com/nanoparticle-labeled-stem-cells-a-novel-therapeutic-vehicle-peer-reviewed-article-CPAA</link>
				<guid isPermaLink="true">http://dovepress.com/nanoparticle-labeled-stem-cells-a-novel-therapeutic-vehicle-peer-reviewed-article-CPAA</guid>
			</item>
	    			<item>
    			<title><![CDATA[The pharmacokinetics of valganciclovir prophylaxis in pediatric solid organ transplant patients at risk for Epstein&ndash;Barr virus disease]]></title>
				<description><![CDATA[Heather&nbsp;E Vezina, Richard C Brundage, Thomas&nbsp;E Nevins, et al]]></description>
				<link>http://dovepress.com/the-pharmacokinetics-of-valganciclovir-prophylaxis-in-pediatric-solid--peer-reviewed-article-CPAA</link>
				<guid isPermaLink="true">http://dovepress.com/the-pharmacokinetics-of-valganciclovir-prophylaxis-in-pediatric-solid--peer-reviewed-article-CPAA</guid>
			</item>
	    			<item>
    			<title><![CDATA[Chronic fluoxetine treatment increases daytime melatonin synthesis in the rodent]]></title>
				<description><![CDATA[Gillian W Reierson, Claudio A Mastronardi, Julio Licinio, et al]]></description>
				<link>http://dovepress.com/chronic-fluoxetine-treatment-increases-daytime-melatonin-synthesis-in--peer-reviewed-article-CPAA</link>
				<guid isPermaLink="true">http://dovepress.com/chronic-fluoxetine-treatment-increases-daytime-melatonin-synthesis-in--peer-reviewed-article-CPAA</guid>
			</item>
	        </channel>
</rss>